ClinicalTrials.gg
Drug

Vorinostat clinical trials

Also written Zolinza, suberoylanilide hydroxamic acid, MSK-390 and MK-0683.

studies test it
235
open now
8
in phase 3
6
first study started
2000

How each study uses Vorinostat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Vorinostat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
6 Oct 2006 · ZOLINZA · NDA 021991 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vorinostat
200
SAHA
110
L-001079038
81
Suberanilohydroxamic Acid
32
suberoylanilide hydroxamic acid (SAHA)
10

Brand

Zolinza
146

Development codes

MSK-390
34
MK-0683
17
NSC 701852
1

Other names

suberoylanilide hydroxamic acid
104

Studies by the year they started

233 studies that test it; most in 2009 (34)

Studies that test Vorinostat, by start year
YearStudies
20001
20011
20031
20042
200527
200622
200717
200825
200934
201023
201112
201214
20138
20147
20158
20165
20179
20182
20192
20203
20212
20241
20253
20264

Who runs them

Industry 28 · Other 207

National Cancer Institute (NCI) (57) · Merck Sharp & Dohme LLC (26) · M.D. Anderson Cancer Center (16) · University of Washington (6) · City of Hope Medical Center (5) · Fred Hutchinson Cancer Center (5) · H. Lee Moffitt Cancer Center and Research Institute (4) · Masonic Cancer Center, University of Minnesota (4)

Often tested with

Tested in the same studies.

Bortezomib (22) · Dexamethasone (8) · Decitabine (8) · Gemcitabine (8) · Lenalidomide (7) · Cytarabine (6) · Doxorubicin (6) · Rituximab (5)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 9

Studies that test Vorinostat.

Studies

Open first, then newest update. How each study uses Vorinostat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 235

See all 235 studies that test Vorinostat →

Given beside what is tested · 25 — Vorinostat is usual care or a partner of the new treatment

Showing 20 of 25.

As the comparator · 3 — what is tested is compared with Vorinostat

Codes

What other systems call Vorinostat · ClinicalTrials.gg INT006704

  • MeSH (NLM) D000077337VorinostatConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 58IFB293JIVORINOSTATConfirmed FDA, NLM, Wikidata
  • RxNorm 194337Confirmed FDA, Wikidata
  • Wikidata Q905901vorinostatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1796VorinostatOne source FDA
  • DrugBank DB02546One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.